Kuehne+Nagel and Moderna announce new international supply chain arrangement to provide distribution and storage of the Covid-19 Vaccine Moderna. This key arrangement will support the worldwide distribution of Moderna’s vaccine from its international supply chain, based in Europe. Distribution will be to markets in Europe, Asia, Middle East and Africa and parts of the Americas. Kuehne+Nagel’s pharma hub in Europe will provide distribution and warehousing and the company will use its network of more than 230 operations worldwide to distribute the vaccine via road and air. Product integrity at the required -20 degrees Celsius will be maintained at all stages of transport and storage.